Serological evaluation of 52 children immunized with the combined measles, mumps and rubella vaccine.
Fifty-two of 298 children vaccinated with the measles-mumps-rubella (MMR) vaccine at around the age of 16 months were evaluated for antibody titres against measles, mumps, and rubella. The seropositivity rates for measles, mumps, and rubella were 86%, 92%, and 98%, respectively. While the most prominent side effects were irritability (6.04%) and fever (4.69%), 83.55% of the vaccinated children showed no undesirable reaction to the vaccine. The MMR vaccine appeared to be immunogenic and nonreactogenic for the children in the study.
Topal
B
B
Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Kanra
G
G
Ceyhan
M
M
D000914:Antibodies, Viral / Q000032:analysis; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D008458:Measles Vaccine / Q000008:administration & dosage; D009108:Mumps Vaccine / Q000008:administration & dosage; D012189:Retrospective Studies; D012411:Rubella Vaccine / Q000008:administration & dosage; D014611:Vaccination / Q000379:methods*; D014765:Viral Vaccines / Q000008:administration & dosage* / Q000009:adverse effects
D000914:Antibodies, Viral; D008458:Measles Vaccine; D009108:Mumps Vaccine; D012411:Rubella Vaccine; D014765:Viral Vaccines